Key facts
- This page summarizes 5AM Ventures V, L.P.'s Form 4 filing for Cabaletta Bio, Inc. (CABA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Nov 2021, 16:38.
5AM Ventures V, L.P. - 01 Nov 2021 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CABA
- Reported as of
- 01 Nov 2021
- Net transaction value
- -$3,835,000
- SEC form
- 4
- Accepted by SEC
- 03 Nov 2021, 16:38:23 UTC
- Prior SEC filing
- 28 Oct 2021
- Next SEC filing
- 04 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- 5AM Ventures V, L.P., By: 5AM Partners V, LLC, its General Partner, By /s/ Scott M. Rocklage, Managing Member
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
5AM Ventures V, L.P. filed Form 4 for Cabaletta Bio, Inc. (CABA) on 03 Nov 2021.
Change
- Previous filing in this sequence was filed on 28 Oct 2021.
- Current net transaction value: -$3,835,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CABA
transaction
Common Stock
Sale
- Transaction value
- $3,359,928
- Shares
- -258,456
- Change %
- -13%
- Price
- $13.00
- Shares after
- 1,731,119
- Date
- 01 Nov 2021
- Ownership
- See footnotes
- Footnotes
- F1
CABA
transaction
Common Stock
Sale
- Transaction value
- $475,072
- Shares
- -36,544
- Change %
- -9.9%
- Price
- $13.00
- Shares after
- 333,144
- Date
- 01 Nov 2021
- Ownership
- See footnotes
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
5AM Ventures V, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein.
Footnote F2
Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein.